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A feature is a single measurable criterion to an observation of a process. While knowledge 
discovery techniques successfully contribute to many fields, however, the extensive required data 
processing could hinder the performance of these techniques. One of the main issues in processing 
data is the dimensionality of the data. Therefore, focusing on reducing the data dimensionality 
through eliminating the insignificant attributes could be considered one of the successful steps for 
raising the applied techniques’ performance. On the other hand, focusing on the applied field, 
ovarian cancer patients continuously suffer from the extensive analysis requirements for detecting 
the disease as well as monitoring the treatment progress. Therefore, identifying the most significant 
required analysis could be a positive step to reduce the emotional and financial suffering. This 
research aims to reduce the data dimensionality of the ovarian cancer disease and highlight the 
most significant analysis using the collaboration of clustering techniques and statistical techniques. 
The research succeeded to identify twelve significant analysis out of forty-four with a total of 
fourteen significant attributes for ovarian cancer data. 
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A feature is a single measurable criterion to 
an observation of a process. Artificial 
intelligence (AI) makes use of the feature 
criterion in any machine learning algorithm 
especially in clustering as well as 
classification problems [1]. In gene data 
analysis or medical related problems, feature 
selection techniques are typically used to find 
the most informative genes and how 
differentially expressed genes are discovered 
[2]. However, the main concern of feature 
selection is to focus on a subset of variables; 
representing the features; which can 
effectively manipulate the input data while 
minimizing the redundancy and removing the 
irrelevant attributes as well as noisy data if 
exists [3]. Based on the expansion of the 
applications of machine learning or pattern 
recognition, the domain of features has been 
significantly increased from tens to hundreds 
of attributes or features applied in those 
applications [4]. As different research 
targeted the health sector [5], it is a fact that 
several approaches are developed to point the 
problem of minimizing irrelevant and 
redundant dimensions. For that, feature 
selection or attribute minimization keeps 
track of all the given information (input data) 
and tries to analyze, understand data, and 
extract the important attributes targeting to 
minimizing the effect of dimensionality to 
improve prediction effectiveness [6].  
The feature or gene data in the medical field 
maintains a very high probability of 
containing numerous numbers of attributes, 
in addition to that, most of these attributes 
probably participate with other attributes in a 
correlation manner (e.g., when two features 
are perfectly correlated, only one feature is 
sufficient to describe the data). So, the 
dependent attributes provide no further 
details about the labels, also can be 
represented as a noise over the prediction. All 
the available information can be extracted 
and maintained through minimum number of 
features. These features uniquely correspond 
to the whole data which contains maximum 
gain of information about the labels. Hence 
by excluding these dependent attributes, the 
data size which effect the prediction process 
will be reduced, thus the effectiveness of the 
approach increased [7].  
In other cases, not only noisy attributes; 
which have no relation to the labels; slow the 
process, but also may have the ability to bias 
data curve to certain point. This situation 
reduces the algorithm performance as there is 
no sufficient information about the process 
being studied. In addition, many researchers 
studied the main approaches of feature 
selection as listed below [1]: 
1. Filtering Approach 
This approach makes use of the attribute 
ranking mechanisms as the core principle 
criteria for feature selection through 
ordering. These methods are maintained for 
their flexibility and simplicity which have 
been applicable for practical problems. A 
suitable ordering criterion used to score the 
attributes based on a threshold value which 
will be an evidence to exclude all attributes 
below target value. Each feature is evaluated 
separately through its statistical criteria’s, 
there is no specific model used. Thus, it is 
independent of the classifier. The most 
typically used filter methods are: 
o Mutual Information  
o Information Gain (IG) 
o Minimum Redundancy Maximum  
o Correlation based Feature Selection 
(CFS) 
o  Fast correlation-based filter (FCBF)  
o Scoring algorithm  
o Random Forest Ranking  
 
 




2. Wrapper Approach 
Wrapper approach considers the predictor 
and performance as a black box and 
evaluation function respectively to measure 
the attributes’ subset. Since evaluating the 
whole set(s) is represented as a NP-hard 
problem, so an optimal subset can be 
performed based on search algorithms which 
find a subset heuristically. A lot of search 
algorithms can be used to find a subset of 
variables to maximize the evaluation function 
gain for a given machine learning problem. In 
classification, it involves using learning 
mechanisms to extract the core subset. This 
approach merges the classifier with the 
search space which leads to more accuracy 
achieved. First, it begins with a sample of the 
solution, and this sample; which is the 
features’ subset; is measured. Based on the 
fitness function, the wrapper approach risks 
are computation cost and overfitting, the 
following techniques are mainly representing 
the wrapper approach goal, 
o Sequential selection algorithms 
o Genetic Algorithm (GA) 
o Artificial Bee Colony (ABC) 
o Ant Colony Optimization (ACO) 
o Particle Swarm Optimization 
o Black Hole Algorithm (BHA) 
o Harmony Search algorithm (HSA) 
 
3. Hybrid Approach 
The hybrid or ensembled approach is based 
on making use of filter and wrapper 
approaches. The combination of both 
approaches achieves high efficiency through 
two stages; minimizing the feature space 
dimension based on ranking or filtering then 
obtaining the wrapper method to pick the 
optimal feature subset. However, the 
performance accuracy still not guaranteed 
due to the differences of the mechanisms of 
both approaches separately. In addition, the 
ensemble approach proposes that the merge 
process of multi-experts is better than single 
output expert, a single wrapper approach 
accuracy is not guaranteed for different 
datasets [1] [6].   
Therefore, AI data driven solutions for health 
care sector, especially cancer, are considered 
a challenging study and open research area 
for most of researches [8] [3]. Many of these 
researches try to study the impact of artificial 
intelligence on health care [9] [10], especially 
on cancer detection or prediction [11]. The 
emergence of feature (gene) selection has 
encouraged researchers to analyze data with 
high dimensions for reducing dimensionality. 
The cancer became one the most critical 
diseases and the correlated data hold 
numerous information with dependent and 
independent attributes. consequently, 
intelligent techniques are required to extract 
the most important features with extreme 
gain to the application’s performance. This 
paper aims to investigate the most 
influencing attributes for ovarian cancer 
disease data. The remaining of the paper will 
introduce the related work, the research 
significance, the proposed approach, and the 
experimental study results. 
 
2. RELATED WORK 
In this literature the research goes through 
identifying different studies of features 
selection techniques to detect and identify 
different diseases. The authors of [13] stated 
the importance of detecting gynaecological 
cancer stage to decide the treatment plan. The 
stage indicates the degree of spread and 
exacerbation of the cancer. They intended to 
enhance the prediction of gynaecological 
cancers stages, specifically cervical and 
ovarian cancers. The work proposed a 
framework named Revised and Improved 
Feature Subset through Fused Feature 
Selection (RIFSt_2FS). The framework is 
applied on a dataset of cancer patients’ data 
who are diagnosed with cervical or ovarian 
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cancer between 2000 and 2017. The dataset 
was conditionally selected from The SEER 
(Surveillance, Epidemiology, and End 
Results Program) database. The framework is 
a crossbreeding of filter feature selection 
method and wrapper feature selection 
method, which are Relief Algorithm and 
Genetic Algorithm, respectively. The work 
applied the Random Forest classifier for 
cancer stage prediction using the selected 
features achieving accuracy of 97%. 
Another research in [14] believed that the 
early discovery of ovarian cancer increases 
survival chance. Their literature focused on 
simplifying the prediction of ovarian cancer. 
The proposed framework is applied on a 
dataset of 349 Chinese patients with 49 
variables which is collected between 2011 
and 2018 from the Third Affiliated Hospital 
of Soochow University. The dataset was 
partitioned into 68% for training and 32% for 
testing. The Literature achieved the state of 
the art by applying the Minimum 
Redundancy - Maximum Relevance 
(MRMR) feature selection method for 48 
times to each attribute in the dataset. MRMR 
tends to recognize the features with the 
highest power of discrimination between the 
targeted classes with considering the 
existence of correlation between features. 
MRMR succeeded to identify ten significant 
features which are then used to train the 
classification model. The literature employed 
CART algorithm to build a decision tree for 
prediction which resulted in finding the most 
two significant features. The authors 
compared the results accuracy replacing 
MRMR with reliefF feature selection. The 
comparison results highlighted that MRMR 
selected more significant features with higher 
F1 score of classification than reliefF feature 
selection.  The authors also approved that 
using CART decision tree for classification 
reached the best AUC-ROC score when 
compared to using the risk of ovarian 
malignancy algorithm (ROMA) or logistic 
regression for classification. 
Moreover, the literature in [15] considered 
not only the high dimensionality of data, but 
also the heterogeneous nature of multi-omics 
data. A TCGA (The Cancer Genome Atlas) 
dataset of multi-omics ovarian cancer are 
gene level copy number alteration (CNA), 
DNA methylation, and gene expression (GE) 
RNA-Seq, with total of 13877 omics features 
the dataset was exported and pre-processed 
from UCSC Xena cancer genomic browser 
and used on the study. The study proposed a 
double consequent staged framework to 
combine and homogenize multi-omics data. 
The first stage contains single view filters 
that can be any conventional feature selection 
methods. Each filter is associated with a 
switch to be set if the input data is a single 
view data. The second stage contains only 
one filter that could be a multi-view feature 
selection method in case the method will be 
applied directly to the input, otherwise, the 
input specific view data will be concatenated 
as an input to stage2 filter. The work also 
proposed an extension to Minimum 
Redundancy - Maximum Relevance 
(MRMR) feature selection method for multi-
omics data. The extension was named multi 
view Minimum Redundancy - Maximum 
Relevance (mv-MRMR). The mv-MRMR 
idea was to capture the selected features for a 
specific view that represent the maximal 
relevant features among all views. The work 
results demonstrated that predicting ovarian 
cancer using multi-view data is much 
powerful and accurate than using specific-
view data. The results also approved that mv-
MRMR outperforms single-view models.  




Additionally, the authors of [16] indicated a 
limitation of the support vector machine 
recursive feature elimination procedure 
(SVM-RFE), that is, it tries recursively to 
find the best combinations for binary 
classification. The research proposed 
sigFeature, a feature selection algorithm, 
which was based on support vector machine 
and t- statistic. The research argued that the 
proposed algorithm overcomes the indicated 
limitation. The literature testing was 
performed on six microarray data sets of six 
different types of cancer available on Gene 
Expression Omnibus, one of them was a 
dataset of 195 samples of ovarian cancer 
patients. The literature compared sigFeature 
to a three of state-of-the-art algorithms, 
which are Support Vector Machine Recursive 
Feature Elimination (SVM-RFE), Support 
Vector Machine T-Test Recursive Feature 
Elimination algorithm (SVM-T-RFE) and 
Support Vector Machine Bayesian T-Test 
Recursive Feature Elimination 
algorithm (SVM-BT-RFE). The work 
approved that sigFeature not only selects the 
most accurate significant features for 
prediction, but also recognizes the biological 
signature of the dataset among SVM-RFE, 
SVM-T-RFE, and SVM-BT-RFE. The 
signature of the selected features was 
validated using gene set enrichment analysis 
(GSEA) using the Molecular Signatures 
Database (MSigDB). 
More research in [17] focused on the blood 
analysis molecularly or atomically which 
confirmed that it is a promising test to 
diagnose ovarian cancer that could overcome 
the limitations of ultra-sound imaging and 
cancer antigen CA-125 tests. A dataset of 176 
patients’ blood plasma labelled as either 
normal, ovarian cyst or ovarian cancer, 
partitioned into one third for validation and 
two thirds for training. Principal component 
analysis (PCA) scores were used for selecting 
the validation samples. The training partition 
was used to extract the significant features in 
order to predict ovarian cancer. For the 
feature selection phase, SelectKBest 
algorithm and chi-squared test were 
employed. For prediction, a regression model 
based on back-propagation neural network 
was trained with adopting five-fold cross 
validation. The model validation is 
performed on random selected instances. The 
prediction achieved sensitivity of 71.4% and 
specificity of 86.5%. The limitation of blood 
plasma analysis is the time consumption of 
collecting the dataset. 
3. RESEARCH SIGNIFICANCE 
The exhaustive requirements for medical 
examinations of the ovarian cancer detection 
as well as the follow up consequently lead to 
suffering from both physical and financial 
bottlenecks. These bottlenecks have been 
arisen due to the high cost of many of these 
examinations as well as the need for 
continuous medical visits. Following this 
lead has highlighted the current research 
direction. This research targets the 
minimization of the required indications 
which highlight the alarm for detecting 
ovarian cancer as well as the follow up of the 
disease progress. The main research direction 
is to explore the weight of each examination 
contribution in the detection and follow up 
process. 
The examinations are considered as a set of 
attributes which provide a full view for the 
patient case. Following the research approach 
leads to minimizing the required 
examinations by setting the most significant 
examinations’ set which consequently leads 
to minimizing the examinations cost for the 
patient as he will seek for less examinations;’ 
set. On the other hand, following the research 
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approach also leads to preserving the 
patient’s physical conditions to its most 
possible status by avoiding the examinations 
which proved to be less contributing in the 
detection as well as the follow up process. 
 
The following points are listed as a summary 
for the main research significance: 
1. The research highlights the fact that each 
weighting technique has its own 
perspective, therefore, the collaboration 
between different techniques provides a 
wider perspective and consequently, a 
more accurate weighting result. 
2. The contribution of the weighting 
techniques is based on evaluating each 
technique individually by following the 
adapted Saaty method in [22]. the authors 
claim that this evaluation phase provides 
more accurate attributes’ weighting. 
3. As it is confirmed by many researches that 
the nature of the data has its significant 
effect on the selected techniques, 
therefore, exploring the consistent 
weighting techniques’ set will be 
performed based on the nature of the 
ovarian cancer dataset. 
4. On the other hand, the consistent 
weighting techniques are applied targeting 
to explore the most significant attributes’ 
set for ovarian cancer data. 
5. The final attributes’ exploration phase 
includes applying clustering techniques 
for highlighting the correlations between 
the contributing attributes and ensures 
high accuracy in the exploration phase. 
6. The classification technique is then 
applied as a validation phase for exploring 
the significant attributes and ensure the 
correct classification after truncating the 
attributes’ set which represents the final  
7. significant examinations for ovarian 
cancer detection and follow up. 
 
4- THE PROPOSED APPROACH FOR 
EXPLORING THE MOST 
SIGNIFICANT EXAMINATIONS FOR 
OVARIAN CANCER 
 
Measuring the consistency level for each 
attribute is introduced following the adapted 
Saaty method in [22] as a primary path. 
However, further adaptation in [23] has been 
evaluated to provide high classification 
accuracy. The proposed adapted method in 
[23] introduced extending the parameters’ set 
in Saaty method to become ten parameters 
while it was only three parameters in [22]. 
While the main scope of [22] [23] was 
applying adapted Saaty method, in the 
current research, an additional step is 
proposed as a preliminary step targeting for 
higher accurate results. This research 
introduces applying a clustering step to 
ensure the ability to apply the adapted Saaty 
method on the applicable number of 
attributes. As the maximum applicable 
attributes for original Saaty was ten attributes 
and although this criterion was not 
highlighted in [23], however, this research 
follows applying the adapted Saaty method 
with a maximum of ten attributes. Although 
the research focuses on ovarian dataset, 
however, figure 1 illustrates the proposed 
general steps for minimizing the data 
dimensionality, while the following formulas 
identify the main contributing resources of 
the proposed method followed by the 










Weighting techniques’ set Weight_Tech= {wtech1, wtech2,….wtechn | n  ℕ } 
Dataset attributes: Dset_Att = {A1, A2,….Am| m  ℕ } 
 
Processing: 
Clust_Att =  {Ci, ….Cj} 
{ <Ae,…Aq>,…., <Aa,…As> | Ae,  Aq, Aa, As  Dset_Att } 
| Clust_Att| = | Dset_Att| 
Si = Clust_Att (Ci) = {Ae,…Aq} 
 
Output: 
The consistent attributes’ set Consistent_ATT = {Af,….Ak | Af , Ak   Dset_Att } 
Consistent_ATT ⊆ Dset_Att 
 
Algorithm: 
For each cluster Ci 
{ For each attribute Aj where Aj  Si 
 { for each weighting technique wtechn   Weight_Tech 
  { 
   Apply wtechn on Si with label Aj 
   Apply adapted Saaty method for Aj 
   Identify consistency (Aj, wtechn) 
  } 
      Identify consistency_Status (Aj) 
 } 
} 
Determine consistent attributes’ set members (Consistent_ATT) where 
 Consistent_ATT = { Aj} where consistency_Status (Aj) = consistent 
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5- EXPERIMENTAL CASE STUDY 
(OVARIAN CANCER DATA) 
A dataset of ovarian cancer patients is the 
focus of the research’s case study. The 
dataset was available by [24], which targeted 
the prediction of ovarian cancer. The dataset 
has a total of 350 patients’ records while 261 
of them are ovarian cancer patients’ records 
and 139 are benign ovarian tumors’ patients. 
The target of using this dataset is to identify 
the most significant features that could 
discriminate between the two types of 
patients. The dataset records are described by 
a total of 47 features which represent the 
patient medical description including 
demographics, blood routine test, general 
chemistry, and tumor markers. Table 1 
illustrates a description of the describing 
features while table 2 illustrates a sample of 
the patients’ records where type 1 is an 
ovarian cancer patient record while type 2 is 




























































MPV Mean platelet volume full blood Sysmex XE-2100 Calculation method 7.4 12.5 fL 
BASO# Basophil Cell Count full blood Sysmex XE-2100 FCM with semiconductor laser 0 0.06 10^9/L 
PHOS phosphorus serum Beckman Coulter AU5800 Phosphomolyase method 0.7 1.62 mmol/l 
GLU. glucose serum Beckman Coulter AU5800 Glucose oxidase method 3.9 6.1 mmol/l 
CA72-4 Carbohydrate antigen 72-4 serum Roche Cobas 8000 ECLIA 0 7 U/ml 
K kalium serum Beckman Coulter AU5800 ion selective electrode method 3.5 5.3 mmol/l 
AST Aspartate aminotransferase serum Beckman Coulter AU5800 MDH method 6 40 u/l 
BASO% Basophil Cell ratio full blood Sysmex XE-2100 Calculation method 0 1 % 
Mg magnesium serum Beckman Coulter AU5800 XB-I method 0.73 1.3 mmol/l 
CL chlorine serum Beckman Coulter AU5800 ion selective electrode method 99 110 mmol/l 
CEA Carcinoembryonic antigen serum Roche Cobas 8000 ECLIA 0 5 ng/ml 
EO# eosinophil count full blood Sysmex XE-2100 FCM with semiconductor laser 0.02 0.52 10^9/L 
CA19-9 Carbohydrate antigen 19-9 serum Roche Cobas 8000 ECLIA 0 37 U/ml 
ALB albumin serum Beckman Coulter AU5800 bromcresol green method 35 55 g/l 
IBIL Indirect bilirubin serum Beckman Coulter AU5800 Calculation 2 15 umol/L 
GGT Gama glutamyltransferasey serum Beckman Coulter AU5800 Rate method 3 73 u/l 
MCH Mean corpuscular hemoglubin full blood Sysmex XE-2100 Calculation method 27 34 Pg 
GLO globulin serum Beckman Coulter AU5800 Calculation 20 40 g/l 
ALT Alanine aminotransferase serum Beckman Coulter AU5800 Lactate dehydrogenase method 1 45 u/l 
DBIL direct bilirubin serum Beckman Coulter AU5800 Vanadate oxidation 1.5 7 umol/l 
RDW red blood cell distribution width full blood Sysmex XE-2100 Calculation method 10.6 15.5 % 
PDW Platelet distribution width full blood Sysmex XE-2100 Calculation method 15.5 18.1 % 
CREA creatinine serum Beckman Coulter AU5800 Jaffe method 44 144 umol/l 
AFP alpha-fetoprotein serum Roche Cobas 8000 ECLIA 0 7 ng/ml 
HGB hemoglobin full blood Sysmex XE-2100 SLS-Hemoglobin method 110 150 g/l 
Na Natrium serum Beckman Coulter AU5800 ion selective electrode method 137 147 mmol/l 
HE4 human epididymis protein 4 serum Roche Cobas 8000 ECLIA 0 140 pmol/L 
LYM# lymphocyte count full blood Sysmex XE-2100 FCM with semiconductor laser 1.1 3.2 10^9/L 
CA125 Carbohydrate antigen 125 serum Roche Cobas 8000 ECLIA 0 35 U/ml 
BUN blood urea nitrogen serum Beckman Coulter AU5800 Urease-glutamic acid dehydrogenase 1.7 8.3 mmol/l 
LYM% lymphocyte ratio full blood Sysmex XE-2100 Calculation method 20 50 % 
Ca calcium serum Beckman Coulter AU5800 Arsenazo III method 1.12 1.32 mmol/l 
AG Anion gap serum Beckman Coulter AU5800 Calculation 8 30 mmol/l 
MONO# mononuclear cell count full blood Sysmex XE-2100 FCM with semiconductor laser 0.1 0.6 10^9/L 
PLT platelet count full blood Sysmex XE-2100 Hydrodynamic Focusing DC method 125 350 10^9/L 
NEU neutrophil ratio full blood Sysmex XE-2100 Calculation method 40 75 % 
EO% eosinophil ratio full blood Sysmex XE-2100 Calculation method 0.02 0.52 10^9/L 
TP Total protein serum Beckman Coulter AU5800 Biuret method 60 82 g/l 
UA urie acid serum Beckman Coulter AU5800 Urease method 90 450 μmol/l 
RBC Red blood cell count full blood Sysmex XE-2100 Hydrodynamic Focusing DC method 3.5 5.5 10^12/L 
PCT thrombocytocrit full blood Sysmex XE-2100 Calculation method 0.114 0.282 L/L 
CO2CP carban dioxide-combining Power serum Beckman Coulter AU5800 Enzymatic method 18 30 mmol/l 
TBIL total bilirubin serum Beckman Coulter AU5800 Vanadate oxidation 4 19 μmol/l 
HCT hematocrit full blood Sysmex XE-2100 Hydrodynamic Focusing DC method 0.35 0.45 L/L 
MONO% monocyte ratio full blood Sysmex XE-2100 Calculation method 3 10 % 
MCV mean corpuscular volume full blood Sysmex XE-2100 Calculation method 82 100 fL 
ALP Alkaline phosphatase serum Beckman Coulter AU5800 NPP substrate-AMP buffer method 25 130 u/l 
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Table 2: A sample of Ovarian Cancer patients’ Dataset [24] (transposed) 
TYPE 0 0 0 0 1 1 1 1 
MPV 11.7 10 11.4 7.38 9.4 6.76 11.4 10.6 
BASO# 0.01 0.02 0.03 0.05 0.01 0.06 0 0.02 
PHOS 1.46 1.09 0.97 1.25 1.2 1.14 1.01 1.42 
GLU. 4.67 10.5 4.64 4.76 5.8 4.71 4.46 4.46 
K 5.36 4.38 4.3 4.7 4.33 4.59 4.06 4.05 
AST 24 13 18 17 24 10 12 19 
BASO% 0.3 0.3 0.6 0.74 0.2 0.72 0.6 0.7 
Mg 0.78 0.82 1 1.11 1.21 0.98 1.05 1.11 
Menopause 0 1 0 1 0 0 0 0 
CL 107.4 100.1 102.6 103.2 97.4 99.3 96.5 100.2 
CEA 1.4 2.46 0.77 0.82 1.9 1.29 0.9 1.38 
EO# 0.04 0.04 0.03 0 0.06 0 0 0.04 
CA19-9 36.48 19.98 12.18 18.41 11.66 12.44 9.65 14.22 
ALB 45.4 39.9 45.4 39.2 48.3 41.2 44 34.8 
IBIL 3.5 4.2 10.1 8 4.1 3.2 5.7 6.3 
GGT 16 13 10 17 20 11 11 18 
MCH 33.7 26.2 28.4 30.6 29.4 30.1 31.2 28.6 
GLO 28.5 32.1 32.5 26.9 28.7 27.8 35.5 37.8 
ALT 11 9 9 16 28 13 11 18 
DBIL 2 2.6 4.7 2.9 2.5 2.5 2.9 3.2 
Age 47 61 39 45 30 26 28 32 
RDW 13.7 12.7 12 14.6 12.3 14 13 12.5 
PDW 13.4 11.2 15.2 17.4 10.4 16.5 16.3 11.5 
CREA 103 45 48 65.7 74.5 60.3 49.2 58 
AFP 3.58 34.24 1.5 2.75 0.61 4.16 0.61 0.77 
HGB 89 128 131 123 151 128 129 129 
Na 141.3 142 138.9 139.1 140.4 136.3 138.9 139.1 
HE4 208.5527 934.1 47.56 853.5 47.61 38.79 42.2 40.94 
LYM# 0.65 1.27 1.1 1.73 2.13 1.33 1.8 1.33 
CA125 15.36 2444 56.08 2555 69.13 35.98 17.8 13.99 
BUN 5.35 3.21 3.8 5.27 5.31 3.18 3.75 4.3 
LYM% 16.8 17.2 23.7 27.2 36 17.2 39.6 43.54 
Ca 2.48 2.62 2.57 2.35 2.43 2.56 2.47 2.45 
AG 19.36 23.98 18.4 16.6 22.63 17.09 23.76 20.75 
MONO# 0.22 0.41 0.25 0.42 0.37 0.3 0.3 0.37 
PLT 74 304 112 339 227 219 213 173 
NEU 76.2 76.5 69.7 65.5 56.5 78.2 53.3 42.44 
EO% 1 0.5 0.6 0.07 1 0 0.4 1.3 
TP 73.9 72 77.9 66.1 77 69 79.5 72.6 
UA 396.4 119.2 209.2 215.6 195.9 157.7 258 167.3 
RBC 2.64 4.89 4.62 4.01 5.13 4.27 4.14 4.51 
PCT 0.09 0.3 0.13 0.25 0.21 0.148 0.243 0.18 
CO2CP 19.9 22.3 22.2 24 24.7 24.5 22.7 22.2 
TBIL 5.5 6.8 14.8 10.9 6.6 5.7 8.6 9.5 
HCT 0.273 0.417 0.391 0.372 0.457 0.388 0.374 0.386 
MONO% 5.7 5.5 5.4 6.55 6.3 3.83 6.1 12.14 
MCV 103.4 85.3 84.6 92.6 89.1 91 90.4 85.6 
ALP 56 95 77 26 76 33 67 51 
 
Clustering the attributes’ set has been applied 
using k-means algorithm with initiating the 
number of clusters to be five clusters [25]. 
This research have followed the proposed 
approach in [23] in order to identify the most 
suitable number of clusters. In order to 
perform the required attributes’ clustering, 
the dataset has been transposed and the k-
means algorithm has been applied, table 3 




illustrates the five clusters’ attributes’ 
members. 
 
Table 3: Attributes’ Clusters Members 
 No. of members Attributes 
cluster 0 20 
BASO#, BASO%, BUN, Ca, CEA, DBIL, EO#, EO%, GLU., HCT, K, LYM#, Menopause, 
Mg, MONO#, MONO%, MPV, PCT, RBC, PHOS 
cluster 1 14 
AFP, AG, ALT, AST, CA72-4, CO2CP, GGT, GLO, IBIL, LYM%, MCH, PDW, RDW, 
TBIL 
cluster 2 11 Age, ALB, ALP, CA19-9, CL, CREA, HGB, MCV, Na, TP, NEU 
cluster 3 2 CA125, HE4 
cluster 4 2 PLT, UA 
 
Following the proposed approach in [23], the 
research tackled the argument the 
consistency of the weighting measures 
follows different criteria including the 
applied methods’ approach as well as the 
nature of data. The research in [23] examined 
a set of weighting methods against the 
Gastrology data, the set included “Principle 
Component Analysis (PCA), Information 
Gain, Information Gain Ratio, Support 
Vector Machine (SVM), Gini Index, Chi 
Square, Deviation, and Correlation”. The 
result of the examination highlighted five to 
six out of the eight measures to be consistent 
with the Gastrology dataset, they are 
“Information Gain, Information Gain Ratio, 
Support Vector Machine, Deviation, Chi-
Square, and Correlation”. Referring to the 
attributes’ types, the authors reached a 
conclusion that the Gastrology dataset has the 
same medical data nature as the ovarian 
cancer dataset. Therefore, the current 
research adopts the same weighting measures 
subset as consistent for ovarian cancer 
patients’ data. Consequently, the current 
research adopts the same approach in 
applying the six consistent weighting 
measures. Following the proposed approach, 
the attributes’ consistency has been measured 
using the weighting measures that belong to 
the consistent measures’ set. As previously 
mentioned, the set was described by 49 
attributes after excluding the patients’ ID 
attribute. According to the experiment 
results, table 4 illustrates the weight for each 
attribute using the consistent weighting 
measures’ set members.  
Demonstrating the original attributes’ weight 
has been performed to highlight the effect of 
applying the proposed approach targeting to 
explore the consistent attributes as the most 
significant attributes. The next stage is 
determining the attributes’ consistency, the 
proposed method for consistency exploration 
has been applied on each cluster members 
individually. As previously highlighted that 
the adapted Saaty method follows the same 
nature of the original Saaty which states that 
the method is applicable up to 10 attributes 
[22]. The following presents the results for 
applying the stage steps over “Menopause” 
attribute as an example for applying the stage 
steps.   
To explore the consistency for each attribute, 
the attribute under examination is set to be the 
label attribute and the weighting for the other 
cluster members is performed for the six 
clusters. Following the example on focus, 
“Menopause” attribute has been identified as 
the label attribute, then the weighting 
measures have been applied on the remaining 
cluster members. Table 4 presents the 
adapted weight for the contributing attributes 
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Table 4: Weight for cluster 0 attributes’ members with considering the “Menopause” attribute as the label 
attribute. 
  IGR deviation chi squared correlation IG SVM PCA 
Mg 0.08 0.01 0.02 0.02 0 0.07 -0.01 
BASO# 0.03 0 0.03 0.09 0.01 0.06 0.01 
DBIL 0.08 0.01 0.04 0.07 0.01 0.01 -0.01 
CEA 0.08 0.02 0.03 0.04 0.06 0.01 0.01 
MONO% 0.16 0.01 0.02 0.03 0.02 0.01 0.01 
MONO# 0.08 0.01 0.03 0.12 0.01 0.01 0.01 
EO# 0.07 0.01 0.02 0.1 0.02 0.08 -0.01 
HCT 0.16 0.01 0.04 0.06 0.01 0.02 0.01 
K 0.18 0.01 0.05 0 0.02 0.05 0.01 
EO% 0.1 0.01 0.02 0.11 0.03 0.06 -0.01 
RBC 0.18 0.01 0.04 0.07 0.03 0 0.01 
PHOS 0.16 0.01 0.01 0.07 0.01 0.09 -0.01 
PCT 0.09 0.01 0.03 0.18 0.02 0.02 0.01 
BASO% 0.08 0.01 0.04 0.17 0.04 0.02 -0.01 
MPV 0.18 0.01 0.04 0.05 0.01 0.14 -0.01 
Ca 0.1 0.01 0.06 0.22 0.05 0.07 -0.01 
LYM# 0.16 0.01 0.05 0.23 0.05 0.07 -0.01 
BUN 0.19 0.01 0.12 0.34 0.11 0.23 0.01 
GLU. 0.24 0.01 0.15 0.4 0.13 0.16 0.01 
 
It is illustrated in table 3 that Menopause 
attribute is a member in cluster 0 which 
included 20 attributes. As the research 
follows the adapted Saaty method, which is 
limited to 10 attributes, therefore, the highest 
weighted attributes in the same cluster have 
been selected for exploring the consistency 
status. Therefore, the consistency of 
Menopause attributes has been examined 
with the contribution of a subset of cluster 0 
which has the highest weight with respect to 
the weighting measure on focus as the 
following clarifying the applied process. 
Table 5 presents these contributing attributes 
for each weighting Technique. 
 
Table 5: Contributing attributes in each weighting measure with “Menopause” attribute as the label 
attribute. 
Weighting Measure Contributing Attribute 
Information Gain Ratio Ca, MONO%, HCT, PHOS, LYM#, K, RBC, MPV, BUN, GLU. 
Information Gain K, PCT, EO%, RBC, BASO%, Ca, LYM#, CEA, BUN, GLU. 
Chi-Square DBIL, HCT, RBC, BASO%, MPV, K, LYM#, Ca, BUN, GLU. 
Correlation BASO#, EO#, EO%, MONO#, BASO%, PCT, Ca, LYM#, BUN, GLU. 
Support Vector Machine BASO#, EO%, Mg, Ca, LYM#, EO#, PHOS, MPV, GLU., BUN 
Deviation RBC, PHOS, PCT, BASO%, MPV, Ca, LYM#, BUN, GLU., CEA 
 
Following the presented attributes’ set that is 
illustrated in table 6, the adapted Saaty 
method has been applied as proposed in [23], 
ten measure have contributed to exploring the 
“Menopause” attribute consistency status, 
they are the minimum, maximum, mean, 
median, range, upper inter-quartile range, 
lower inter-quartile range, mean of upper 
inter-quartile range and the mean value, and 
mean of lower inter quartile range and the 
mean value of λ. Finally, the same 
consistency threshold is below or equal 0.3 
which has been identified as the maximum 
acceptable percentage for consistency [22]. 
 
According to these weights, the proposed 
adapted Saaty method has been applied and 
the attribute’s consistency has been 
measured. The following groups of 
illustrations presents different 




situations. Table 6 illustrates the values for 
the adapted Saaty method parameters of 
“Menopause” attribute and the contribution 
of the highest weighted ten attributes whish 
are members in the same cluster with respect 
to “information gain ratio” weighting 
Technique. According to the results in table 
6, then table 7 illustrates the λ Measures for 
which concluded the Menopause” attribute 
consistency with respect to information gain 
ration weighting Technique while figure 2 
presents a graphical distribution of the 𝜆' 
measures. The presented 𝜆' measures values 
in table 7 highlighted the fact that the 
consistency of the Menopause” attribute is 
neutral as illustrated in table 8 that five of the 
𝜆' measures are consistent while five of them 
are not. 
 
Table 6: adapted Saaty method parameters of “Menopause” attribute WRT Information Gain Ratio 
Weighting Technique 
 IGR 1 2 3 4 5 6 7 8 9 10 Product Eigen Vector 
1 1.00 0.38 0.38 0.38 0.19 0.13 0.30 0.30 0.17 0.38 0.31 0.03 
2 2.07 1.00 1.00 1.00 0.50 0.33 0.80 0.89 0.45 1.00 0.80 0.07 
3 2.07 1.00 1.00 1.00 0.50 0.33 0.80 0.89 0.45 1.00 0.80 0.07 
4 2.07 1.00 1.00 1.00 0.50 0.33 0.80 0.89 0.45 1.00 0.80 0.07 
5 5.33 2.00 2.00 2.00 1.00 0.67 1.60 6.70 0.89 2.00 1.88 0.16 
6 8.00 3.00 3.00 3.00 1.50 1.00 2.40 2.67 1.34 3.00 2.47 0.21 
7 3.33 1.25 1.25 1.25 0.63 0.42 1.00 9.00 0.56 1.25 1.27 0.11 
8 3.00 1.13 1.13 1.13 0.56 0.38 0.90 1.00 0.50 1.13 0.93 0.08 
9 6.00 2.25 2.25 2.25 1.13 0.75 1.80 2.00 1.00 2.25 1.85 0.16 
10 2.07 1.00 1.00 1.00 0.50 0.33 0.80 0.89 0.45 1.00 0.80 0.07 
           11.90  
 
Table 7: λ Measures for Menopause” attribute WRT Information Gain Ratio Weighting Technique 
 L C.I C.R Consitency 
Lmax 14.0955823 0.4550647 0.78459432 Not Const. 
Lmean 10.7877072 0.08752302 0.15090176 Const. 
Lmedian 10.3113509 0.03459455 0.05964578 Const. 
Lmin 10.2755728 0.03061919 0.05279171 Const. 
range 6.82000958 -0.3533323 -0.6091936 Not Const. 
StDev 1.21556483    
interQuartile range 
14.4344017 0.4927113 0.84950224 Not Const. 
7.14101267 -0.3176653 -0.5476987 Not Const. 
mean(rang,UpperQ) 10.6272056 0.06968951 0.12015434 Const. 
mean(rang,LowerQ) 6.98051113 -0.3354988 -0.5784461 Not Const. 
mean(range, mean) 8.80385838 -0.1329046 -0.2291459 Const. 
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Figure 2: Distribution of λ Measures for “Menopause” attribute WRT Information Gain Ratio Weighting 
Technique 
 
Table 8: Count and Percentage of Consistency status in 𝜆' measures 
 Count Percentage 
Consistent 𝜆' measures 5 50% 
Non-Consistent 𝜆' measures 5 50% 
 
The similar steps have been applied for each 
weighting technique, for more clarification, 
tables 9, 10, and 11 illustrate the same 
sequence of steps for the “Menopause” 
attribute is consistency status with respect to 
the deviation weighting technique with 
graphical illustration of λ Measures 
distribution in figure 3. The presented results 
highlight the fact that the “Menopause” 
attribute is consistent as illustrated in table 9 
that six of the 𝜆' measures are consistent 
while four of them are not. 
 
Table 9: adapted Saaty method parameters of “Menopause” attribute WRT Deviation Weighting Technique 
 
 Deviation 1 2 3 4 5 6 7 8 9 10 Product Eigen Vector 
1 1.00 1.00 1.00 1.00 1.00 1.00 0.10 0.11 0.06 0.13 0.39 0.02 
2 1.00 1.00 1.00 1.00 1.00 1.00 0.10 0.11 0.06 0.13 0.39 0.02 
3 1.00 1.00 1.00 1.00 1.00 1.00 0.10 0.11 0.06 0.13 0.39 0.02 
4 1.00 1.00 1.00 1.00 1.00 1.00 0.10 0.11 0.06 0.13 0.39 0.02 
5 1.00 1.00 1.00 1.00 1.00 1.00 0.10 0.11 0.06 0.13 0.39 0.02 
6 1.00 1.00 1.00 1.00 1.00 1.00 0.10 0.11 0.06 0.13 0.39 0.02 
7 10.00 10.00 10.00 10.00 10.00 10.00 1.00 1.11 0.56 1.25 3.88 0.20 
8 9.00 9.00 9.00 9.00 9.00 9.00 0.90 1.00 0.50 1.13 3.49 0.18 
9 18.00 18.00 18.00 18.00 18.00 18.00 1.80 2.00 1.00 2.25 6.98 0.35 
10 8.00 8.00 8.00 8.00 8.00 8.00 0.80 0.89 0.44 1.00 3.10 0.16 












Table 10: λ Measures for Menopause” attribute WRT Deviation Weighting Technique 
 L C.I C.R Consitency 
Lmax 10 0 0 Const. 
Lmean 10 0 0 Const. 
Lmedian 10 0 0 Const. 
Lmin 10 0 0 Const. 
range 3 -0.7777778 -1.3409962 Not Const. 
StDev 0    
interQuartile range 
10 0 0 Const. 
10 0 0 Const. 
mean(rang,UpperQ) 6.5 -0.3888889 -0.6704981 Not Const. 
mean(rang,LowerQ) 6.5 -0.3888889 -0.6704981 Not Const. 







Figure 3: Distribution of λ Measures for “Menopause” attribute WRT Deviation Weighting Technique 
 
Table 11: Count and Percentage of Consistency status in 𝜆' measures 
 Count Percentage 
Consistent 𝜆' measures 6 60% 
Non-Consistent 𝜆' measures 4 40% 
 
Moreover, as a final example, tables 13, 14, 
and 15 illustrate the same sequence of steps 
for the “Menopause” attribute is consistency 
status with respect to the deviation weighting 
technique with graphical illustration of λ 
Measures distribution in figure 4. The 
presented results highlight the fact that the 
“Menopause” attribute is not consistent as 
illustrated in table 15 that four of the 𝜆' 
measures are consistent while six of them are 
not. 
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Table 12: adapted Saaty method parameters of “Menopause” attribute WRT Support Vector Machine 
Weighting Technique 
 SVM 1 2 3 4 5 6 7 8 9 10 Product Eigen Vector 
1 1.00 3.00 6.00 6.00 3.00 0.38 0.86 3.00 0.86 0.75 1.70 0.14 
2 0.33 1.00 2.00 2.00 1.00 0.13 0.29 1.00 0.11 0.25 0.52 0.04 
3 0.17 0.50 1.00 1.00 0.50 0.06 0.14 0.50 0.06 0.13 0.26 0.02 
4 0.17 0.50 1.00 1.00 0.50 0.06 0.14 0.50 0.06 0.13 0.26 0.02 
5 0.33 1.00 2.00 2.00 1.00 0.13 0.29 1.00 0.11 0.25 0.52 0.04 
6 2.67 8.00 16.00 16.00 8.00 1.00 2.29 8.00 0.89 2.00 4.12 0.34 
7 1.17 3.50 7.00 7.00 3.50 0.44 1.00 3.50 0.39 0.88 1.80 0.15 
8 0.33 1.00 2.00 2.00 1.00 0.13 0.29 1.00 0.11 0.25 0.52 0.04 
9 1.17 3.50 7.00 7.00 3.50 0.44 1.00 3.50 1.00 0.88 1.98 0.17 
10 0.17 0.50 1.00 1.00 0.50 0.06 0.14 0.50 0.06 1.00 0.32 0.03 
           11.99  
 
Table 13: λ Measures for “Menopause” attribute WRT Support Vector Machine Weighting Technique 
 L C.I C.R Consitency 
Lmax 8.68035137 -0.1466276 -0.2528063 Const. 
Lmean 8.57064173 -0.1588176 -0.2738234 Const. 
Lmedian 8.68035137 -0.1466276 -0.2528063 Const. 
Lmin 7.9256362 -0.2304849 -0.3973877 Not Const. 
range 3.75471517 -0.6939205 -1.1964147 Not Const. 
StDev 0.23754424    
interQuartile range 
9.28327445 -0.0796362 -0.1373037 Const. 
7.85800901 -0.237999 -0.4103431 Not Const. 
mean(rang,UpperQ) 6.51899481 -0.3867784 -0.6668592 Not Const. 
mean(rang,LowerQ) 5.80636209 -0.4659598 -0.8033789 Not Const. 




Figure 4: Distribution of λ Measures for “Menopause” attribute WRT Support Vector Machine Weighting 
Technique 
 
Table 14: Count and Percentage of Consistency status in 𝜆' measures 
 Count Percentage 
Consistent 𝜆' measures 4 40% 
Non-Consistent 𝜆' measures 6 60% 
 




Finally, table 16 presents the final decision 
considering the consistency status of the 
“Menopause” attribute. As shown in table 16, 
the “Menopause” attribute is consistent for 
three weighting technique, neutral for two 
weighting technique and not consistent for 
only one technique. Therefore, the final 
decision is considering the “Menopause” 
attribute to be consistent. This decision 
reveals that the “Menopause” attribute will 
be considered in the final attributes’ set for 
the ovarian cancer patients’ data. 
 















Consistent Neutral Not Consistent Neutral Consistent Consistent Consistent 
 
The same process is then performed for the 
remaining attributes targeting to reach the 
final attributes’ set. Each of the attributes is 
examined following the same process with 
respect to its own cluster members as 
previously discussed for the “Menopause” 
attribute. Table 17 illustrates the final 
decision for all attributes. It is worth 
highlighting that only the highest weighted 
ten 
attributes for each cluster are considered in 
the exploration phase with eliminating other 
attributes without examination, the attribute 
has the sign C if it is consistent and the sign 
NC if it is not consistent. According to the 
consistency status for the attributes’ set 
members, the final attributes set is 
determined to include all consistent attributes 
as illustrated in table 18 to be 26 attributes out 
of 49 attributes. 
 
Table 16: Consistency status for all attributes 
Cluster 0 Cluster 1 Cluster 2 
Mg NC RBC NC TBIL NC HGB NC 
BASO# NC PHOS NC ALT NC TP NC 
DBIL NC PCT C MCH NC CL C 
CEA NC BASO% NC IBIL C CA19-9 C 
MONO% NC MPV C GLO C PDW NC 
MONO# NC Ca C AFP C CREA NC 
EO# C LYM# C AG C MCV C 
HCT NC BUN C GGT C ALB NC 
K C GLU. NC CO2CP NC ALP NC 
EO% C Menopause C LYM% C NEU C 
Cluster 3 Cluster 4 RDW NC Na C 
HE4 C PLT C AST C Age C 
CA125 C UA NC CA72-4 C   
 
Table 17: Final Attributes’ set members 
EO# K MPV LYM# Menopause AST AG GLO IBIL CL NEU Age HE4 
PCT EO% Ca BUN LYM% CA72-4 GGT AFP MCV CA19-9 Na PLT CA125 
 
As a validation step, the ID3 classification 
technique [26] and KNN are applied on the 
dataset after eliminating the non-consistent 
attributes to ensure that the elimination step 
provides accurate classification with no 
effect on the accuracy as illustrated in table 
19. The selection of ID3 and KNN for the 
classification task follows the research in 
[27] which compared the performance of a 
set of techniques for medical data. Although 
the research in [27]  applied the techniques on 
Tinnitus patients’ dataset and reached a 
conclusion that KNN and neural networks 
have the highest accuracy, however, the 
current research applied KNN and ID3 to 
confirm this conclusion. 
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Table 18: Performance measures for KNN classification Technique 
 
Evaluation measure Value 
accuracy 81.58% 







This research aimed to apply a set of steps 
targeting to highlight the most significant 
analysis for ovarian cancer disease. The 
research approach was to identify the highest 
weighted attributes in the ovarian cancer 
patients’ dataset. The dataset was a 
benchmark which originally included ninety 
four attributes which describe the set of 
analysis for the patients. A total of three 
hundred and fifty records were included in 
the dataset, it was divided into two hundred 
and sixty one ovarian cancer patients while 
the remaining records were benign ovarian 
tumors. The research also highlighted the 
applicability of the successful collaboration 
between statistical and mining techniques for 
the required attributes’ exploration task. The 
proposed method succeeded in minimizing 
the set of analysis into twenty four with a 
percentage of 42% attributes’ minimization. 
Although the current research succeeded to 
reach its aim, however, more research 
directions could be suggested. Applying the 
proposed method on different datasets with 
different nature is one of the directions. 
Moreover, inspecting different clustering 
techniques could be further enhancement to 
confirm the heist performance. 
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